Behnood Bikdeli and Colleagues Summarize 2025 ACC/AHA Recommendations for Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared an insightful post on X:
“We summarized the guideline recs for anticoagulant and antiplatelettherapy in ACS and compared them with prior recs in ACCinTouch, AHAScience and escardio guidelines. Writing Committee and also a great team who made this summary possible.”
Title: Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations
Auhors: Behnood Bikdeli, Francisco Ujueta, Sina Rashedi, Azita H. Talasaz, Kushal T. Kadakia, Renato D. Lopes, Harvey D. White, Philippe Gabriel Steg, Gregory Piazza, Rasha K. Al-Lamee, David J. Cohen, Roxana Mehran, and Harlan M. Krumholz
Read the full article here.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis